Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Race Oncology Ltd. ( (AU:RAC) ) has issued an announcement.
Race Oncology Ltd has announced the quotation of 1,125 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 2, 2025. This move is part of the company’s strategy to enhance its market presence and provide additional liquidity for its securities, potentially benefiting stakeholders by increasing the company’s visibility and accessibility in the financial markets.
More about Race Oncology Ltd.
Race Oncology Ltd is a company in the biotechnology industry, focusing on the development and commercialization of cancer therapies. The company is primarily engaged in advancing its proprietary drug candidates to address unmet needs in oncology.
Average Trading Volume: 93,281
Technical Sentiment Signal: Sell
Current Market Cap: A$207.6M
For detailed information about RAC stock, go to TipRanks’ Stock Analysis page.